This Surgical Robot Could Transform the Operating Room

Johnson and Johnson received FDA approval for its surgical robot Ottava following years of development and hundreds of millions of dollars in investment. The approval allows the company to enter the surgical robotics market, where competitors including Intuitive Surgical have established significant market presence. The robot's commercial performance will depend on hospital adoption rates and clinical outcomes in operating room use.

Next story